Spatial Omics Market

AI Assisted Healthcare is fueling the growth of the Spatial Omics Market

by

The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Spatial omics refers to a set of techniques that map out the location of biomolecules, like DNA, RNA, and proteins, within intact cells and tissue samples. It allows researchers and pathologists to gain a better understanding of molecular organization and interaction within tissues. Spatial omics help gain insights into complex biological systems by preserving the context dependent relationships between genes and proteins that regular ‘omics’ techniques lose in homogenized samples.

Market key trends:
Advances in spatial microscopy and analytics platforms coupled with a growing interest in tissue architecture and microenvironments are driving the adoption of spatial omics techniques. Integration of multi-omics approaches like transcriptomics, proteomics and genomics at single-cell resolution within intact tissue morphology contexts offer a comprehensive view of molecular organization. Newer precision applications in areas like disease diagnosis, drug target discovery and precision medicine have increased investments in developing more automated and high-throughput spatial profiling methods.

Segment Analysis
The global spatial omics market is segmented into – microscopy, sequencing, mass spectrometry and other technologies. Among these, microscopy segment holds the largest market share owing to its wide usage in capturing high-resolution images of biological tissues and cells. Microscopy is further segmented into fluorescence microscopy, confocal microscopy, electron microscopy, etc. Among these fluorescence microscopy dominates the microscopy segment as it allows localization of multiple proteins and molecules in tissues and cells simultaneously with high sensitivity.

Key Takeaways

Global Spatial Omics Market Demand is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing focus on disease diagnosis at spatial resolution.

Regional analysis:
North America holds the largest share in the spatial omics market owing to presence of major key players and availability of advanced healthcare technologies. Asia Pacific is expected to witness fastest growth rate over the forecast period owing growing biotechnology industry and increasing R&D investments in the region.

Market size: The global spatial omics market size was valued at US$ 292.1 Mn in 2023 and is expected to reach over US$ 600 Mn by 2030.

Key players: Key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. 10x Genomics dominates the market owing to its wide product portfolio for spatial genomics applications.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it